Potential Therapeutic Action of Autophagy in Gastric Cancer Managements: Novel Treatment Strategies and Pharmacological Interventions

• Published in: Frontiers in pharmacology Vol. 12; p. 813703
• Main Authors: Rahman, Md Ataur, Ahmed, Kazi Rejvee, Rahman, Md Hasanur, Park, Moon Nyeo, Kim, Bonglee
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 28-01-2022
• Subjects: autophagy; autophagy modulator; autophagy-related genes; gastric cancer; Pharmacology; phytochemical; tumorigenesis; autophagy; tumorigenesis; gastric cancer; autophagy-related genes; autophagy modulator; phytochemical
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2021.813703

Gastric cancer (GC), second most leading cause of cancer-associated mortality globally, is the cancer of gastrointestinal tract in which malignant cells form in lining of the stomach, resulting in indigestion, pain, and stomach discomfort. Autophagy is an intracellular system in which misfolded, aggregated, and damaged proteins, as well as organelles, are degraded by the lysosomal pathway, and avoiding abnormal accumulation of huge quantities of harmful cellular constituents. However, the exact molecular mechanism of autophagy-mediated GC management has not been clearly elucidated. Here, we emphasized the role of autophagy in the modulation and development of GC transformation in addition to underlying the molecular mechanisms of autophagy-mediated regulation of GC. Accumulating evidences have revealed that targeting autophagy by small molecule activators or inhibitors has become one of the greatest auspicious approaches for GC managements. Particularly, it has been verified that phytochemicals play an important role in treatment as well as prevention of GC. However, use of combination therapies of autophagy modulators in order to overcome the drug resistance through GC treatment will provide novel opportunities to develop promising GC therapeutic approaches. In addition, investigations of the pathophysiological mechanism of GC with potential challenges are urgently needed, as well as limitations of the modulation of autophagy-mediated therapeutic strategies. Therefore, in this review, we would like to deliver an existing standard molecular treatment strategy focusing on the relationship between chemotherapeutic drugs and autophagy, which will help to improve the current treatments of GC patients.